Gene Fusions

All
Insights
Investors
Board of Directors
Leadership
Uncategorized
Our Partners
Scientific Advisory Committee
Publications
Newsroom

October 26, 2020

Posters & Oral Presentations

The anti-HER3 monoclonal antibody seribantumab effectively inhibits growth of patient-derived and isogenic cell line and xenograft models with NRG1 rearrangements

Presented at EORTC-NCI-AACR 2020

Presenting Author: Igor Odintsov, MD; Memorial Sloan Kettering Cancer Center

Read More

Pages: 12